Early events of BCC tumorigenesis are triggered by inappropriate activation of SHH signaling, via the loss of Patched1 (Ptch1) or by activating mutations of Smoothened (Smo) [41]. The gene discussed is SMO; the disease is skin basal cell carcinoma.